Clinical Trials

A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)

​

Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer (USZ-STRIKE)

​

A Study of NVL-655  (new ALK TKI targeting ALK and resistance mutations) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Nuvalent Trial

Lorlatinib Activity Based on ALK Resistance Mutations Detected on Blood (ALKALINE)

​

Lorlatinib with ALK-Positive  NSCLC 
(which has progressed on first-line certinib or alectinib)

Alectinib: Deciphering anti tumor response and resistance
with intratumor heterogenicity
(Darwin II)

Navigational Bronchoscopy for ablation of tumours in the lung - a trial at the Royal Brompton.

Go to details for a press report

A trial to ascertain whether presribing an anticoagulant together with a TKI will reduce the incidence of blood clots. (NOMADIC